Sabra Reports Fourth Quarter 2017 Results; Closes on Enlivant Investments; Provides Update on CCP Merger Execution; Provides Update on Genesis Exodus; Updates 2018 Earnings Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Go back to Sabra Reports Fourth Quarter 2017 Results; Closes on Enlivant Investments; Provides Update on CCP Merger Execution; Provides Update on Genesis Exodus; Updates 2018 Earnings Guidance
February 22, 2018 6:57 AM EST
Stifel lowered its price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $21.00 (from $22.00) while maintaining a Hold rating.
...
More